Companies: 10,795·Total market cap: $144.5T
Summit Therapeutics Inc.

Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active
$14.50
$-0.27(-1.84%)
Market Cap$11.2B
P/E Ratio
52W High$30.98
52W Low$13.83

Summit Therapeutics Inc. (SMMT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SMMT · as of Jun 8, 2026

Activity summary

Buy transactions

11

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Summit Therapeutics Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

SMMT insider buying and selling by quarter

SMMT insider selling · SMMT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
50.0M25.0M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · SMMT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SMMT executive sell shares · SMMT board member insider trading · SMMT insider trading SEC filing

Showing 33 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

Date

Jun 4

Shares

100,000

Price

$14.60

Value

$1.46M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

Date

Jun 4

Shares

100,000

Price

$14.60

Value

$1.46M ⚡

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Purchase

Date

Jun 4

Shares

25,000

Price

$14.43

Value

$361K

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Purchase

Date

Jun 4

Shares

25,000

Price

$14.46

Value

$362K

View Form 4 on SEC.gov

Xia Yu

Director

Purchase

Date

Oct 21

Shares

533,617

Price

$18.74

Value

$10.00M ⚡

View Form 4 on SEC.gov

Anand Bhaskar

CAO

Award

Date

Oct 21

Shares

26,680

Price

$18.74

Value

$500K

View Form 4 on SEC.gov

Soni Manmeet Singh

COO and CFO · Director

Award

Date

Oct 21

Shares

53,361

Price

$18.74

Value

$1000K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

Date

Oct 21

Shares

13,980,789

Price

$18.74

Value

$262.00M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

Date

Oct 21

Shares

266,808

Price

$18.74

Value

$5.00M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

Date

Oct 21

Shares

26,680

Price

$18.74

Value

$500K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

Date

Oct 21

Shares

13,980,789

Price

$18.74

Value

$262.00M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

Date

Oct 21

Shares

266,808

Price

$18.74

Value

$5.00M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

Date

Oct 21

Shares

26,680

Price

$18.74

Value

$500K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

Date

Sep 11

Shares

5,000

Price

$18.07

Value

$90K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Purchase

Date

Sep 10

Shares

333,394

Price

$17.68

Value

$5.89M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

Date

Sep 11

Shares

5,000

Price

$18.07

Value

$90K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Purchase

Date

Sep 10

Shares

333,394

Price

$17.68

Value

$5.89M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Option

Date

May 30

Shares

74,545

Price

$2.64

Value

$197K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Option

Date

May 30

Shares

74,545

Price

$2.64

Value

$197K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Other

Date

Apr 8

Shares

3,985,055

Price

$1.58

Value

$6.30M ⚡

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Other

Date

Apr 8

Shares

3,985,055

Price

$1.58

Value

$6.30M ⚡

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Other

Date

Oct 3

Shares

315,681

Price

$1.58

Value

$499K

View Form 4 on SEC.gov

Zanganeh Mahkam

Co-Chief Executive Officer · Director

Award

Date

Sep 11

Shares

44,052

Price

$22.70

Value

$1000K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Co-Chief Executive Officer · Director

Award

Date

Sep 11

Shares

3,325,991

Price

$22.70

Value

$75.50M ⚡

View Form 4 on SEC.gov

Huber Jeff

Director

Award

Date

Sep 11

Shares

44,052

Price

$22.70

Value

$1000K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SMMT insider trading

SMMT insider trades

Summit Therapeutics Inc. (SMMT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DUGGAN ROBERT W (Co-Chief Executive Officer · Director), Zanganeh Mahkam (Co-Chief Executive Officer · Director), Soni Manmeet Singh (COO and CFO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. SMMT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Summit Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

SMMT insider trading · 5 questions

The insiders of Summit Therapeutics Inc. (SMMT) include executives and directors such as DUGGAN ROBERT W (Co-Chief Executive Officer · Director), Zanganeh Mahkam (Co-Chief Executive Officer · Director), Soni Manmeet Singh (COO and CFO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SMMT board member insider tradingwho are SMMT insidersSMMT insider rosterSummit Therapeutics Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026